These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8894591)

  • 1. Prevention of methamphetamine-induced behavioral sensitization in rats by a cyclic AMP phosphodiesterase inhibitor, rolipram.
    Iyo M; Bi Y; Hashimoto K; Inada T; Fukui S
    Eur J Pharmacol; 1996 Sep; 312(2):163-70. PubMed ID: 8894591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does an increase of cyclic AMP prevent methamphetamine-induced behavioral sensitization in rats?
    Iyo M; Bi Y; Hashimoto K; Tomitaka SI; Inada T; Fukui S
    Ann N Y Acad Sci; 1996 Oct; 801():377-83. PubMed ID: 8959050
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of a selective cAMP phosphodiesterase inhibitor, rolipram, on methamphetamine-induced behavior.
    Iyo M; Maeda Y; Inada T; Kitao Y; Sasaki H; Fukui S
    Neuropsychopharmacology; 1995 Aug; 13(1):33-9. PubMed ID: 8526969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of rolipram, a selective inhibitor of phosphodiesterase 4, on hyperlocomotion induced by several abused drugs in mice.
    Mori T; Baba J; Ichimaru Y; Suzuki T
    Jpn J Pharmacol; 2000 Jun; 83(2):113-8. PubMed ID: 10928323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of oro-facial movements by rolipram, a cAMP phosphodiesterase inhibitor, in rats chronically treated with haloperidol.
    Sasaki H; Hashimoto K; Inada T; Fukui S; Iyo M
    Eur J Pharmacol; 1995 Aug; 282(1-3):71-6. PubMed ID: 7498291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo.
    Wachtel H
    J Pharm Pharmacol; 1983 Jul; 35(7):440-4. PubMed ID: 6136585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of cyclic AMP systems in morphine physical dependence in mice: prevention of development of morphine dependence by rolipram, a phosphodiesterase 4 inhibitor.
    Mamiya T; Noda Y; Ren X; Hamdy M; Furukawa S; Kameyama T; Yamada K; Nabeshima T
    Br J Pharmacol; 2001 Mar; 132(5):1111-7. PubMed ID: 11226142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors.
    Griebel G; Misslin R; Vogel E; Bourguignon JJ
    Pharmacol Biochem Behav; 1991 Jun; 39(2):321-3. PubMed ID: 1658815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats.
    Itoh T; Tokumura M; Abe K
    Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rolipram, a phosphodiesterase-4-selective inhibitor, promotes the survival of cultured rat dopaminergic neurons.
    Yamashita N; Hayashi A; Baba J; Sawa A
    Jpn J Pharmacol; 1997 Oct; 75(2):155-9. PubMed ID: 9414030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway.
    Eckly AE; Lugnier C
    Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside.
    Turner NC; Lamb J; Worby A; Murray KJ
    Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular effects induced by rolipram, a selective cAMP phosphodiesterase inhibitor: interaction with adrenergic and calcium affecting drugs.
    Novara V; Flugy A; Antona A; Latteri S; Palazzoadriano M; Cannizzaro G
    Pharmacol Res; 1990; 22 Suppl 1():51-2. PubMed ID: 2178260
    [No Abstract]   [Full Text] [Related]  

  • 14. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors.
    Wachtel H
    Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of cyclic AMP phosphodiesterases in the actions of ibudilast on eosinophil thromboxane generation and airways smooth muscle tone.
    Souness JE; Villamil ME; Scott LC; Tomkinson A; Giembycz MA; Raeburn D
    Br J Pharmacol; 1994 Apr; 111(4):1081-8. PubMed ID: 8032594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rolipram, a selective c-AMP phosphodiesterase inhibitor suppresses oro-facial dyskinetic movements in rats.
    Sasaki H; Hashimoto K; Maeda Y; Inada T; Kitao Y; Fukui S; Iyo M
    Life Sci; 1995; 56(25):PL443-7. PubMed ID: 7791505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facilitation of dopaminergic neural transmission does not affect [(11)C]SCH23390 binding to the striatal D(1) dopamine receptors, but the facilitation enhances phosphodiesterase type-IV activity through D(1) receptors: PET studies in the conscious monkey brain.
    Tsukada H; Harada N; Ohba H; Nishiyama S; Kakiuchi T
    Synapse; 2001 Dec; 42(4):258-65. PubMed ID: 11746724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of type-selective phosphodiesterase inhibitors on glucose-induced insulin secretion and islet phosphodiesterase activity.
    Shafiee-Nick R; Pyne NJ; Furman BL
    Br J Pharmacol; 1995 Aug; 115(8):1486-92. PubMed ID: 8564209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolation of similar rolipram-inhibitable cyclic-AMP-specific phosphodiesterases from rat brain and heart.
    Némoz G; Moueqqit M; Prigent AF; Pacheco H
    Eur J Biochem; 1989 Oct; 184(3):511-20. PubMed ID: 2553394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram.
    Kochetkova M; Burns FM; Souness JE
    Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.